PEBP1 and triple-A syndrome: These findings suggest that nanovesicles, by delivering PEBP1 mRNA, effectively activate the NRF2/GPX4 axis, reducing intracellular oxidative stress and iron ion toxicity and potentially attenuating VSMC damage associated with AAA.